Navigating the future of drug development at the C-Path Global Impact Conference

FHS
August 8, 2024
11:38 am

Critical Path Institute (C-Path), whose mission is to lead collaborations that accelerate drug development, advancing better treatments for people worldwide, is proud to announce its inaugural C-Path Global Impact Conference (CGIC), taking place from September 9-11, 2024, at the Washington Marriott at Metro Center.

8 Common Physician Credentialing Mistakes to Watch in 2024

Charlie Falcone, CEO at Verisys Corporation If you find credentialing uninspiring, consider this cautionary tale. In a frequently cited negligent credentialing case, an Illinois jury

February 6, 2024

Inventiva secures up to $380m for MASH treatment lanifibranor – Pharmaceutical Technology

The FDA approved the first treatment for MASH in March this year. Image credit: Shutterstock/ Iurii Motov. Inventiva has secured up to €348m ($380m) in

October 14, 2024

Upadacitinib Shows Long-Term Benefits in Teens With Atopic Dermatitis

Treatment with the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) showed a favorable long-term benefit-risk profile through 76 weeks in adolescents with moderate to severe atopic

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.